Follow the people · Insider
Hannah Valantine
Hannah Valantine files insider transactions with the SEC as a director of CareDx (CDNA). We hold 6 disclosed purchases and sales filed since 21 June 2021, 4 of them in the last 90 days.
- Files forCDNA
- Disclosed buys and sells6 in all, 4 in the last 90 days
- Last disclosure17 July 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 July 2021 — 16 July 2026Director · CareDx (CDNA)25 Form 4 lines · source: SEC Form 4
- Filed 25 October 2021 — 23 June 2026Director · BridgeBio Pharma (BBIO)59 Form 4 lines · source: SEC Form 4
- Filed 16 June 2021 — 3 June 2026Director · Pacific Biosciences Of California (PACB)7 Form 4 lines · source: SEC Form 4
Everything they disclosed
91 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 7,606 shares of CareDxSEC Form 417 July 2026Common Stock · traded 16 July 2026 · filed 17 July 2026
- exercised options over 16,048 shares of CareDxSEC Form 417 July 2026Common Stock · traded 16 July 2026 · filed 17 July 2026
- exercised options over 5,125 shares of CareDxSEC Form 417 July 2026Common Stock · traded 16 July 2026 · filed 17 July 2026
- ▼ sold on the open market 28,679 shares of CareDxSEC Form 417 July 2026Common Stock · traded 16 July 2026 · filed 17 July 2026
- ▼ sold on the open market 100 shares of CareDxSEC Form 417 July 2026Common Stock · traded 16 July 2026 · filed 17 July 2026
- exercised options over 7,606 shares of CareDx (a derivative holding)SEC Form 417 July 2026Stock Option (Right to Buy) · traded 16 July 2026 · filed 17 July 2026
- exercised options over 16,048 shares of CareDx (a derivative holding)SEC Form 417 July 2026Stock Option (Right to Buy) · traded 16 July 2026 · filed 17 July 2026
- exercised options over 5,125 shares of CareDx (a derivative holding)SEC Form 417 July 2026Stock Option (Right to Buy) · traded 16 July 2026 · filed 17 July 2026
- was granted 3,990 shares of BridgeBio PharmaSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- exercised options over 2,808 shares of BridgeBio PharmaSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▼ sold on the open market 2,808 shares of BridgeBio PharmaSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▼ sold on the open market 2,196 shares of BridgeBio PharmaSEC Form 424 June 2026Common Stock · traded 23 June 2026 · filed 24 June 2026
- was granted 5,277 shares of BridgeBio Pharma (a derivative holding)SEC Form 424 June 2026Stock Option (Right to Buy) · traded 22 June 2026 · filed 24 June 2026
- exercised options over 2,808 shares of BridgeBio Pharma (a derivative holding)SEC Form 424 June 2026Stock Option (Right to Buy) · traded 22 June 2026 · filed 24 June 2026
- was granted 9,795 shares of CareDxSEC Form 416 June 2026Common Stock · traded 12 June 2026 · filed 16 June 2026
- ▼ sold on the open market 12,103 shares of CareDxSEC Form 416 June 2026Common Stock · traded 15 June 2026 · filed 16 June 2026
- was granted 223,492 shares of Pacific Biosciences Of California (a derivative holding)SEC Form 44 June 2026Stock Option (right to buy) · traded 3 June 2026 · filed 4 June 2026
- exercised options over 8,671 shares of BridgeBio PharmaSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- ▼ sold on the open market 8,671 shares of BridgeBio PharmaSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- exercised options over 8,671 shares of BridgeBio Pharma (a derivative holding)SEC Form 412 March 2026Stock Option (Right to Buy) · traded 10 March 2026 · filed 12 March 2026
- exercised options over 8,671 shares of BridgeBio Pharma (a derivative holding)SEC Form 412 March 2026Stock Option (Right to Buy) · traded 10 March 2026 · filed 12 March 2026
- exercised options over 8,671 shares of BridgeBio PharmaSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- ▼ sold on the open market 8,671 shares of BridgeBio PharmaSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- exercised options over 25,484 shares of BridgeBio PharmaSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 14,584 shares of BridgeBio PharmaSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 10,900 shares of BridgeBio PharmaSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- exercised options over 25,484 shares of BridgeBio Pharma (a derivative holding)SEC Form 43 March 2026Stock Option (Right to Buy) · traded 27 February 2026 · filed 3 March 2026
- exercised options over 25,484 shares of BridgeBio Pharma (a derivative holding)SEC Form 43 March 2026Stock Option (Right to Buy) · traded 27 February 2026 · filed 3 March 2026
- exercised options over 25,484 shares of BridgeBio PharmaSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 14,584 shares of BridgeBio PharmaSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 10,900 shares of BridgeBio PharmaSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- exercised options over 25,484 shares of BridgeBio Pharma (a derivative holding)SEC Form 414 November 2025Stock Option (Right to Buy) · traded 12 November 2025 · filed 14 November 2025
- exercised options over 25,484 shares of BridgeBio PharmaSEC Form 414 November 2025Common Stock · traded 12 November 2025 · filed 14 November 2025
- ▼ sold on the open market 25,484 shares of BridgeBio PharmaSEC Form 414 November 2025Common Stock · traded 12 November 2025 · filed 14 November 2025
- ▲ bought on the open market 1,542 shares of BridgeBio PharmaSEC Form 430 June 2025Common Stock · traded 28 December 2021 · filed 30 June 2025
- ▲ bought on the open market 796 shares of BridgeBio PharmaSEC Form 430 June 2025Common Stock · traded 28 December 2021 · filed 30 June 2025
- ▲ bought on the open market 1,752 shares of BridgeBio PharmaSEC Form 430 June 2025Common Stock · traded 29 December 2021 · filed 30 June 2025
- ▼ sold on the open market 876 shares of BridgeBio PharmaSEC Form 430 June 2025Common Stock · traded 26 June 2025 · filed 30 June 2025
- ▼ sold on the open market 1,542 shares of BridgeBio PharmaSEC Form 430 June 2025Common Stock · traded 26 June 2025 · filed 30 June 2025
- ▼ sold on the open market 398 shares of BridgeBio PharmaSEC Form 430 June 2025Common Stock · traded 26 June 2025 · filed 30 June 2025
- ▼ sold on the open market 1,891 shares of BridgeBio PharmaSEC Form 430 June 2025Common Stock · traded 26 June 2025 · filed 30 June 2025
- was granted 8,425 shares of BridgeBio Pharma (a derivative holding)SEC Form 424 June 2025Stock Option (Right to Buy) · traded 20 June 2025 · filed 24 June 2025
- was granted 6,589 shares of BridgeBio PharmaSEC Form 424 June 2025Common Stock · traded 20 June 2025 · filed 24 June 2025
- ▼ sold on the open market 10,570 shares of CareDxSEC Form 423 June 2025Common Stock · traded 18 June 2025 · filed 23 June 2025
- was granted 12,103 shares of CareDxSEC Form 417 June 2025Common Stock · traded 13 June 2025 · filed 17 June 2025
- exercised options over 4,292 shares of BridgeBio Pharma (a derivative holding)SEC Form 411 June 2025Stock Option (right to buy) · traded 10 June 2025 · filed 11 June 2025
- exercised options over 4,292 shares of BridgeBio PharmaSEC Form 411 June 2025Common Stock · traded 10 June 2025 · filed 11 June 2025
- ▼ sold on the open market 4,292 shares of BridgeBio PharmaSEC Form 411 June 2025Common Stock · traded 10 June 2025 · filed 11 June 2025
- was granted 65,000 shares of Pacific Biosciences Of California (a derivative holding)SEC Form 46 June 2025Stock Option (right to buy) · traded 4 June 2025 · filed 6 June 2025
- exercised options over 12,875 shares of BridgeBio Pharma (a derivative holding)SEC Form 410 March 2025Stock Option (right to buy) · traded 6 March 2025 · filed 10 March 2025
- exercised options over 12,875 shares of BridgeBio PharmaSEC Form 410 March 2025Common Stock · traded 6 March 2025 · filed 10 March 2025
- ▼ sold on the open market 12,875 shares of BridgeBio PharmaSEC Form 410 March 2025Common Stock · traded 6 March 2025 · filed 10 March 2025
- was granted 26,014 shares of BridgeBio Pharma (a derivative holding)SEC Form 425 June 2024Stock Option (Right to Buy) · traded 21 June 2024 · filed 25 June 2024
- was granted 16,048 shares of CareDx (a derivative holding)SEC Form 420 June 2024Stock Option (right to buy) · traded 14 June 2024 · filed 20 June 2024
- was granted 32,179 shares of Pacific Biosciences Of California (a derivative holding)SEC Form 420 June 2024Stock Option (right to buy) · traded 18 June 2024 · filed 20 June 2024
- was granted 22,821 shares of Pacific Biosciences Of CaliforniaSEC Form 420 June 2024Common Stock · traded 18 June 2024 · filed 20 June 2024
- was granted 16,048 shares of CareDx (a derivative holding)SEC Form 418 June 2024Stock Option (right to buy) · traded 14 June 2024 · filed 18 June 2024
- was granted 10,570 shares of CareDxSEC Form 418 June 2024Common Stock · traded 14 June 2024 · filed 18 June 2024
- exercised options over 2,915 shares of BridgeBio Pharma (a derivative holding)SEC Form 420 February 2024Stock Option (right to buy) · traded 15 February 2024 · filed 20 February 2024
- exercised options over 2,915 shares of BridgeBio PharmaSEC Form 420 February 2024Common Stock · traded 15 February 2024 · filed 20 February 2024
- ▼ sold on the open market 2,915 shares of BridgeBio PharmaSEC Form 420 February 2024Common Stock · traded 15 February 2024 · filed 20 February 2024
- ▲ bought on the open market 1,891 shares of BridgeBio PharmaSEC Form 413 February 2024Common Stock · traded 28 December 2021 · filed 13 February 2024
- ▲ bought on the open market 1,542 shares of BridgeBio PharmaSEC Form 413 February 2024Common Stock · traded 28 December 2021 · filed 13 February 2024
- ▲ bought on the open market 1,891 shares of BridgeBio PharmaSEC Form 413 February 2024Common Stock · traded 28 December 2021 · filed 13 February 2024
- ▲ bought on the open market 1,542 shares of BridgeBio PharmaSEC Form 413 February 2024Common Stock · traded 28 December 2021 · filed 13 February 2024
- exercised options over 2,915 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 January 2024Stock Option (right to buy) · traded 16 January 2024 · filed 18 January 2024
- exercised options over 2,915 shares of BridgeBio PharmaSEC Form 418 January 2024Common Stock · traded 16 January 2024 · filed 18 January 2024
- ▼ sold on the open market 2,915 shares of BridgeBio PharmaSEC Form 418 January 2024Common Stock · traded 16 January 2024 · filed 18 January 2024
- exercised options over 2,915 shares of BridgeBio Pharma (a derivative holding)SEC Form 419 December 2023Stock Option (right to buy) · traded 15 December 2023 · filed 19 December 2023
- exercised options over 2,915 shares of BridgeBio PharmaSEC Form 419 December 2023Common Stock · traded 15 December 2023 · filed 19 December 2023
- ▼ sold on the open market 2,915 shares of BridgeBio PharmaSEC Form 419 December 2023Common Stock · traded 15 December 2023 · filed 19 December 2023
- exercised options over 2,915 shares of BridgeBio Pharma (a derivative holding)SEC Form 417 November 2023Stock Option (right to buy) · traded 15 November 2023 · filed 17 November 2023
- exercised options over 2,915 shares of BridgeBio PharmaSEC Form 417 November 2023Common Stock · traded 15 November 2023 · filed 17 November 2023
- ▼ sold on the open market 2,915 shares of BridgeBio PharmaSEC Form 417 November 2023Common Stock · traded 15 November 2023 · filed 17 November 2023
- was granted 51,501 shares of BridgeBio Pharma (a derivative holding)SEC Form 423 June 2023Stock Option (right to buy) · traded 21 June 2023 · filed 23 June 2023
- was granted 29,136 shares of CareDx (a derivative holding)SEC Form 421 June 2023Common Stock · traded 16 June 2023 · filed 21 June 2023
- was granted 18,844 shares of CareDxSEC Form 421 June 2023Common Stock · traded 16 June 2023 · filed 21 June 2023
- was granted 25,775 shares of Pacific Biosciences Of California (a derivative holding)SEC Form 426 May 2023Stock Option (right to buy) · traded 24 May 2023 · filed 26 May 2023
- was granted 676 shares of CareDxSEC Form 49 January 2023Common Stock · traded 6 January 2023 · filed 9 January 2023
- was granted 422 shares of CareDxSEC Form 44 October 2022Common Stock · traded 4 October 2022 · filed 4 October 2022
- was granted 325 shares of CareDxSEC Form 46 July 2022Common Stock · traded 1 July 2022 · filed 6 July 2022
- was granted 104,921 shares of BridgeBio Pharma (a derivative holding)SEC Form 424 June 2022Stock Option (right to buy) · traded 22 June 2022 · filed 24 June 2022
- was granted 7,606 shares of CareDx (a derivative holding)SEC Form 421 June 2022Common Stock · traded 16 June 2022 · filed 21 June 2022
- was granted 4,863 shares of CareDxSEC Form 421 June 2022Common Stock · traded 16 June 2022 · filed 21 June 2022
- was granted 63,015 shares of Pacific Biosciences Of California (a derivative holding)SEC Form 427 May 2022Stock Option (right to buy) · traded 25 May 2022 · filed 27 May 2022
- ▲ bought on the open market 1,764 shares of BridgeBio PharmaSEC Form 43 January 2022Common Stock · traded 29 December 2021 · filed 3 January 2022
- was granted 50,968 shares of BridgeBio Pharma (a derivative holding)SEC Form 426 October 2021Stock Option (right to buy) · traded 25 October 2021 · filed 26 October 2021
- was granted 131 shares of CareDxSEC Form 44 October 2021Common Stock · traded 1 October 2021 · filed 4 October 2021
- was granted 1,630 shares of CareDx (a derivative holding)SEC Form 42 July 2021Employee Stock Option (right to buy) · traded 1 July 2021 · filed 2 July 2021
- was granted 1,630 shares of CareDxSEC Form 42 July 2021Common Stock · traded 1 July 2021 · filed 2 July 2021
- was granted 28,992 shares of Pacific Biosciences Of California (a derivative holding)SEC Form 421 June 2021Stock Option (right to buy) · traded 16 June 2021 · filed 21 June 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.